| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $270.25 ▼ -0.88% | Yesterday | $273.67 ▲ +0.37% | Tomorrow's Krystal Biotech Inc. Common Stock (KRYS) setup is anchored to $272.66 and targets $270.25 (-0.88%). The near-term read is downside; watch $280.84 / $264.48 because daily realized volatility is about 4.56%. |
Tomorrow's Krystal Biotech Inc. Common Stock (KRYS) setup is anchored to $272.66 and targets $270.25 (-0.88%). The near-term read is downside; watch $280.84 / $264.48 because daily realized volatility is about 4.56%. | ||||
| Week | $265.16 ▼ -2.75% | Last Week | $275.81 ▲ +1.16% | The 7-day Krystal Biotech Inc. Common Stock model moves from $275.81 to $265.16 (-2.75%). It gives downside momentum context for this stock, so breaks around $280.84 / $264.48 matter more than a single tick. |
The 7-day Krystal Biotech Inc. Common Stock model moves from $275.81 to $265.16 (-2.75%). It gives downside momentum context for this stock, so breaks around $280.84 / $264.48 matter more than a single tick. | ||||
| Month | $256.69 ▼ -5.86% | Last Month | $279.37 ▲ +2.46% | The 1-month Krystal Biotech Inc. Common Stock target is $256.69 (-5.86%), compared with the live reference near $272.66. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Krystal Biotech Inc. Common Stock target is $256.69 (-5.86%), compared with the live reference near $272.66. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $243.99 ▼ -10.51% | Last Year | $284.70 ▲ +4.42% | The 1-year Krystal Biotech Inc. Common Stock scenario points to $243.99 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Krystal Biotech Inc. Common Stock scenario points to $243.99 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $214.23 ▼ -21.43% | 5 Years Ago | $297.20 ▲ +9.00% | The 5-year Krystal Biotech Inc. Common Stock view is $214.23 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Krystal Biotech Inc. Common Stock view is $214.23 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $272.66 | Mid |
| Daily Change | -1.39% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 60% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $272.66 | Daily Change | -1.39% |
| Market Cap | $8.03B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.